Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Annales De Dermatologie Et De Venereologie
|
January 22, 2021
Aggressive locoregional behavior of cutaneous squamous cell carcinoma during ruxolitinib use
M Sauvage, S Tavitian, V Sibaud, et al.
Annales De Dermatologie Et De Venereologie
|
March 9, 2020
[Efficacy of combined paclitaxel/cetuximab in cutaneous squamous-cell carcinoma: A retrospective analysis of 14 patients]
E Casassa, L Riffaud, V Sibaud, et al.
The British Journal of Dermatology
|
December 16, 2014
Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors
E Vigarios, L Lamant, J P Delord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2020
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines<sup>☆</sup>
M E Lacouture, V Sibaud, P A Gerber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 25, 2019
[Treatment of patients with brain metastases from a melanoma]
A Modesto, C Chira, J-C Sol, et al.
The British Journal of Dermatology
|
December 13, 2016
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
A Zarbo, V R Belum, V Sibaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 3, 2017
[Uncommon dermatologic disorders triggered by radiation therapy of breast cancer: A case-series]
C Dalmasso, É Tournier, B de Lafontan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 12, 2014
Acquired perforating dermatosis associated with sorafenib therapy
M Severino-Freire, V Sibaud, E Tournier, et al.
La Revue De Medecine Interne
|
November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]
T Comont, J Belliere, V Sibaud, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 19, 2017
Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings
V Sibaud, C Eid, V R Belum, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Annales De Dermatologie Et De Venereologie
|
January 22, 2021
Aggressive locoregional behavior of cutaneous squamous cell carcinoma during ruxolitinib use
M Sauvage, S Tavitian, V Sibaud, et al.
Annales De Dermatologie Et De Venereologie
|
March 9, 2020
[Efficacy of combined paclitaxel/cetuximab in cutaneous squamous-cell carcinoma: A retrospective analysis of 14 patients]
E Casassa, L Riffaud, V Sibaud, et al.
The British Journal of Dermatology
|
December 16, 2014
Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors
E Vigarios, L Lamant, J P Delord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2020
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines<sup>☆</sup>
M E Lacouture, V Sibaud, P A Gerber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 25, 2019
[Treatment of patients with brain metastases from a melanoma]
A Modesto, C Chira, J-C Sol, et al.
The British Journal of Dermatology
|
December 13, 2016
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
A Zarbo, V R Belum, V Sibaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 3, 2017
[Uncommon dermatologic disorders triggered by radiation therapy of breast cancer: A case-series]
C Dalmasso, É Tournier, B de Lafontan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 12, 2014
Acquired perforating dermatosis associated with sorafenib therapy
M Severino-Freire, V Sibaud, E Tournier, et al.
La Revue De Medecine Interne
|
November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]
T Comont, J Belliere, V Sibaud, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 19, 2017
Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings
V Sibaud, C Eid, V R Belum, et al.
Page
of 8